This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Innovations in Allergy Treatment by Alla Fishman
Introduction
Alla Fishman is an accomplished inventor based in Zichron Yaakov, Israel. She has made significant contributions to the field of allergy treatment through her innovative research and development. Her work focuses on targeted therapies that aim to improve the quality of life for individuals suffering from allergic responses.
Latest Patents
Alla Fishman holds a patent for her invention titled "Fcepsilon-pe chimeric protein for targeted treatment of allergy responses a method for its production and pharmaceutical compositions containing the same." This patent describes a novel approach to therapy for allergic responses, utilizing a chimeric cytotoxin that specifically targets and eliminates cells expressing the FcεRI receptor. The invention details the genetic fusion of a sequence encoding specific amino acids from the mouse IgE molecule to a truncated form of Pseudomonas exotoxin, which effectively kills mast cells associated with allergic reactions. This innovative chimeric protein is not only a breakthrough in allergy treatment but also has potential applications in treating hyperplasias and malignancies.
Career Highlights
Fishman is associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., where she continues her research and development efforts. Her work has garnered attention for its potential to revolutionize the treatment of allergies through targeted therapies. With a focus on scientific innovation, she has contributed to the advancement of medical treatments that address the underlying causes of allergic responses.
Collaborations
Throughout her career, Alla Fishman has collaborated with notable colleagues, including Haya Lorberboum-Galski and Shai Yarkoni. These collaborations have further enhanced her research and contributed to the development of her patented technologies.
Conclusion
Alla Fishman's innovative work in the field of allergy treatment exemplifies the impact of targeted therapies in modern medicine. Her patented chimeric protein represents a significant advancement in the treatment of allergic responses, showcasing her dedication to improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile